Table 1 Top 20 journals with the largest decline in the number of highly-cited papers.
Journal | COVID-19 papers published | number of highly-cited papers | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
JCR 2021 | JCR 2022 | JCR 2018 | JCR 2019 | JCR 2020 | JCR 2021 | JCR 2022 | |||||
% papers | % citations | % papers | % citations | all | all | all | all | non-COVID-19 | all | non-COVID-19 | |
Science | 5.2% | 27.2% | 10.1% | 28.7% | 93 | 86 | 124 | 179 | 118 | 181 | 105 |
Nature | 3.2% | 20.1% | 7.1% | 24.1% | 102 | 117 | 164 | 256 | 196 | 251 | 157 |
CELL | 7.5% | 39.1% | 18.4% | 48.1% | 40 | 55 | 56 | 92 | 45 | 99 | 39 |
Science of The Total Environment | 1.5% | 11.2% | 3.4% | 10% | 0 | 3 | 13 | 79 | 27 | 60 | 32 |
The Lancet | 10% | 52.4% | 24.2% | 52.1% | 73 | 70 | 90 | 120 | 77 | 133 | 73 |
Journal of Medical Virology | 22.6% | 71.2% | 54.2% | 82.6% | 0 | 0 | 0 | 36 | 0 | 18 | 0 |
The New England Journal of Medicine (NEJM) | 7.9% | 37.8% | 16.9% | 50.7% | 100 | 117 | 149 | 160 | 126 | 199 | 110 |
MMWR - Morbidity and Mortality Weekly Report | 29.8% | 65.7% | 54.4% | 77.1% | 7 | 5 | 10 | 43 | 11 | 39 | 6 |
Nature Medicine | 10.7% | 34.6% | 27.4% | 60.5% | 7 | 23 | 44 | 74 | 42 | 77 | 24 |
Nature Communications | 1.2% | 5% | 3.8% | 8.6% | 30 | 40 | 49 | 110 | 83 | 105 | 74 |
Clinical Infectious Diseases | 9.1% | 58.9% | 19.8% | 47.9% | 6 | 2 | 2 | 31 | 5 | 21 | 3 |
JAMA - Journal of the American Medical Association | 6% | 35.3% | 15.3% | 44.8% | 24 | 19 | 24 | 49 | 27 | 55 | 25 |
Lancet Infectious Diseases | 13.7% | 61% | 28.4% | 66.8% | 3 | 3 | 5 | 24 | 3 | 26 | 2 |
Proceedings of the National Academy of Sciences of The United States Of America (PNAS) | 1.7% | 10.3% | 4.8% | 15.7% | 13 | 9 | 22 | 40 | 19 | 38 | 16 |
Psychiatry Research | 5.6% | 62% | 15.7% | 70.8% | 0 | 0 | 0 | 19 | 0 | 22 | 0 |
BMJ - British Medical Journal | 9.2% | 44.4% | 24% | 34.4% | 1 | 2 | 3 | 30 | 11 | 40 | 14 |
Radiology(https://pubs.rsna.org/journal/radiology) | 7% | 51.3% | 13.5% | 48.1% | 2 | 2 | 0 | 18 | 1 | 15 | 2 |
PLoS One | 2.4% | 12.2% | 8.5% | 26.4% | 3 | 2 | 1 | 18 | 1 | 29 | 1 |
Brain Behavior and Immunity | 6.5% | 61% | 8.7% | 54% | 0 | 0 | 0 | 16 | 0 | 12 | 0 |
Lancet Respiratory Medicine | 15.1% | 61.1% | 38.3% | 65.2% | 1 | 2 | 5 | 23 | 7 | 21 | 4 |
